Works matching IS 02770008 AND DT 2022 AND VI 42 AND IP 10
Results: 6
Low‐dose adjuvant dexmedetomidine did not decrease propofol sedation requirements in children undergoing gastrointestinal endoscopy.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 10, p. 792, doi. 10.1002/phar.2729
- By:
- Publication type:
- Article
Time to defervescence evaluation for extended‐ vs. standard‐infusion cefepime in patients with acute leukemia and febrile neutropenia.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 10, p. 798, doi. 10.1002/phar.2728
- By:
- Publication type:
- Article
Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 10, p. 780, doi. 10.1002/phar.2727
- By:
- Publication type:
- Article
Direct oral to parenteral anticoagulant transitions: Role of factor Xa inhibitor‐specific anti‐Xa concentrations.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 10, p. 768, doi. 10.1002/phar.2726
- By:
- Publication type:
- Article
Alopecia signals associated with calcitonin gene‐related peptide inhibitors in the treatment or prophylaxis of migraine: A pharmacovigilance study.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 10, p. 758, doi. 10.1002/phar.2725
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 10, p. 755, doi. 10.1002/phar.2424
- Publication type:
- Article